Simon R. Bramhall

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

Simon R. Bramhall, J Schulz, John Nemunaitis et al. · British Journal of Cancer · 2002 · 560 citations · Full text

Medicine, Oncology, Pharmacology +11

Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial

Simon R. Bramhall, Alexander S. Rosemurgy, Peter de Nully Brown et al. · Journal of Clinical Oncology · 2001 · 434 citations

Medicine, Oncology, Pharmacology +11

Hepatic artery thrombosis following orthotopic liver transplantation: A 10-year experience from a single centre in the United Kingdom

Michael A. Silva, Periyathambi Jambulingam, Bridget Gunson et al. · Liver Transplantation · 2005 · 275 citations · Full text

Medicine, Surgery, Hepatology +13

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

Simon R. Bramhall, M T Hallissey, J Whiting et al. · British Journal of Cancer · 2002 · 267 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin

Daniel H. Palmer, Deborah Stocken, Helen Hewitt et al. · Annals of Surgical Oncology · 2007 · 230 citations

Medicine, Oncology, Chemotherapy +10